Cite
HARVARD Citation
Ghayad, S. et al. (2019). The histone deacetylase inhibitor Suberoylanilide Hydroxamic Acid (SAHA) as a therapeutic agent in rhabdomyosarcoma. Cancer biology & therapy. 20 (3), pp. 272-283. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ghayad, S. et al. (2019). The histone deacetylase inhibitor Suberoylanilide Hydroxamic Acid (SAHA) as a therapeutic agent in rhabdomyosarcoma. Cancer biology & therapy. 20 (3), pp. 272-283. [Online].